GEP201606538B - Preoperative treatment of post operative pain - Google Patents

Preoperative treatment of post operative pain

Info

Publication number
GEP201606538B
GEP201606538B GEAP20049183A GEAP2004009183A GEP201606538B GE P201606538 B GEP201606538 B GE P201606538B GE AP20049183 A GEAP20049183 A GE AP20049183A GE AP2004009183 A GEAP2004009183 A GE AP2004009183A GE P201606538 B GEP201606538 B GE P201606538B
Authority
GE
Georgia
Prior art keywords
operative pain
post operative
preoperative treatment
treatment
preoperative
Prior art date
Application number
GEAP20049183A
Other languages
English (en)
Inventor
Bruce E Reidenberg
Daniel A Spyker
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of GEP201606538B publication Critical patent/GEP201606538B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Processing Of Meat And Fish (AREA)
GEAP20049183A 2003-07-25 2004-07-26 Preoperative treatment of post operative pain GEP201606538B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49036303P 2003-07-25 2003-07-25

Publications (1)

Publication Number Publication Date
GEP201606538B true GEP201606538B (en) 2016-09-12

Family

ID=34115386

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP20049183A GEP201606538B (en) 2003-07-25 2004-07-26 Preoperative treatment of post operative pain

Country Status (27)

Country Link
US (3) US20080026042A1 (cg-RX-API-DMAC7.html)
EP (1) EP1638492B1 (cg-RX-API-DMAC7.html)
JP (1) JP5632573B2 (cg-RX-API-DMAC7.html)
KR (4) KR20060054346A (cg-RX-API-DMAC7.html)
CN (1) CN1829489B (cg-RX-API-DMAC7.html)
AT (1) ATE382354T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004261181B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0412924A (cg-RX-API-DMAC7.html)
CA (1) CA2529983C (cg-RX-API-DMAC7.html)
CY (1) CY1107352T1 (cg-RX-API-DMAC7.html)
DE (1) DE602004011055T2 (cg-RX-API-DMAC7.html)
DK (1) DK1638492T3 (cg-RX-API-DMAC7.html)
EA (1) EA009213B1 (cg-RX-API-DMAC7.html)
ES (1) ES2299871T3 (cg-RX-API-DMAC7.html)
GE (1) GEP201606538B (cg-RX-API-DMAC7.html)
HR (1) HRP20080146T3 (cg-RX-API-DMAC7.html)
IL (1) IL173345A (cg-RX-API-DMAC7.html)
IS (1) IS8186A (cg-RX-API-DMAC7.html)
MA (1) MA28005A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA06000990A (cg-RX-API-DMAC7.html)
NO (1) NO326636B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ594154A (cg-RX-API-DMAC7.html)
PL (1) PL1638492T3 (cg-RX-API-DMAC7.html)
PT (1) PT1638492E (cg-RX-API-DMAC7.html)
UA (1) UA81689C2 (cg-RX-API-DMAC7.html)
WO (1) WO2005011578A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200510071B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE10361306A1 (de) * 2003-12-24 2005-07-28 Lts Lohmann Therapie-Systeme Ag Wundauflage und Wundschnellverband mit einem vasokonstriktorischen Inhaltsstoff, sowie Herstellungsverfahren hierfür
JP2011251944A (ja) * 2010-06-02 2011-12-15 Kansai Medical Univ 埋植用鎮痛製剤
DE102010024105A1 (de) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
US9168251B2 (en) 2010-09-03 2015-10-27 Zoetis Belgium S.A High dose buprenorphine compositions and use as analgesic
RU2459640C2 (ru) * 2010-10-26 2012-08-27 Государственное учреждение здравоохранения "Воронежская областная клиническая больница № 1" Способ послеоперационного обезболивания больных, оперированных под спинальной анестезией
RU2487734C1 (ru) * 2011-11-17 2013-07-20 Анатолий Анатольевич Лаврентьев Способ послеоперационного обезболивания
RU178867U1 (ru) * 2016-05-04 2018-04-20 Общество с ограниченной ответственностью Научно-производственное предприятие "НОК" Вакуумная микроразмерная кристаллизационная ячейка
RU2649961C1 (ru) * 2017-02-28 2018-04-05 Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) Способ обезболивания после проведения операции кесарева сечения у пациенток с избыточной массой тела
EP4583859A2 (en) * 2022-09-09 2025-07-16 The Regents of University of California Compositions for preventing transition from acute to chronic pain

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4119713A (en) * 1977-02-09 1978-10-10 Sam Carosio Analgesic and anti-inflammatory composition
US4806341A (en) * 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
US5026556A (en) * 1988-11-10 1991-06-25 Norwich Eaton Pharmaceuticals, Inc. Compositions for the transdermal delivery of pharmaceutical actives
US5240711A (en) * 1989-11-29 1993-08-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising as active component buprenorphine
AU637496B2 (en) * 1990-04-24 1993-05-27 Teijin Limited Plaster
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
SE9003665D0 (sv) * 1990-11-16 1990-11-16 Kabivitrum Ab Morphine prodrugs
JP2669951B2 (ja) * 1991-03-28 1997-10-29 雍憲 森本 麻薬性鎮痛剤を含有する経皮吸収組成物
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
CA2174803C (en) * 1996-04-23 2000-07-11 Jonathan P. Wong Use of liposome encapsulated ciprofloxacin as an immunotherapeutic drug
JPH1036265A (ja) * 1996-07-19 1998-02-10 Nitto Denko Corp ブプレノルフィン経皮吸収製剤
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US5942530A (en) * 1997-08-28 1999-08-24 Eli Lilly And Company Method for treating pain
KR100383252B1 (ko) * 1998-12-17 2003-07-16 주식회사 삼양사 부프레놀핀을함유하는경피투여조성물및이를포함하는패취
DE19901085C2 (de) * 1999-01-14 2003-12-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps
JP4659943B2 (ja) * 2000-02-25 2011-03-30 帝三製薬株式会社 塩酸ブプレノルフィン含有貼付剤
AU2001262683A1 (en) * 2000-06-02 2001-12-17 Teijin Limited Buprenorphine-containing patch
GB0026137D0 (en) * 2000-10-25 2000-12-13 Euro Celtique Sa Transdermal dosage form
US20020106407A1 (en) * 2000-12-11 2002-08-08 Dennis Coleman Method and apparatus for treating breakthrough pain
DE60235555D1 (de) * 2001-04-23 2010-04-15 Euro Celtique Sa Entsorgungssystem für transdermale dosierformen
DK2316439T3 (en) * 2001-05-01 2015-08-10 Euro Celtique Sa Abuse-proof transdermal systems containing opioids
AU2002339382A1 (en) * 2001-05-22 2002-12-03 Euro-Celtique Container and method for dispensing transdermal dosage forms
US7270830B2 (en) * 2002-12-13 2007-09-18 Purdue Pharma L.P. Transdermal buprenorphine dosage regimen for analgesia

Also Published As

Publication number Publication date
KR20060054346A (ko) 2006-05-22
JP5632573B2 (ja) 2014-11-26
ES2299871T3 (es) 2008-06-01
DK1638492T3 (da) 2008-05-13
CN1829489B (zh) 2010-12-15
EA009213B1 (ru) 2007-12-28
AU2004261181B2 (en) 2009-08-06
EP1638492B1 (en) 2008-01-02
EP1638492A4 (en) 2006-07-19
US20140221413A1 (en) 2014-08-07
US20110002975A1 (en) 2011-01-06
WO2005011578A3 (en) 2005-09-09
WO2005011578A2 (en) 2005-02-10
CY1107352T1 (el) 2012-12-19
IL173345A0 (en) 2006-06-11
HRP20080146T3 (en) 2008-04-30
EA200600284A1 (ru) 2006-06-30
NO20060912L (no) 2006-04-21
NZ594154A (en) 2012-12-21
MXPA06000990A (es) 2006-04-11
CA2529983C (en) 2010-07-20
KR20090031961A (ko) 2009-03-30
CN1829489A (zh) 2006-09-06
KR20120128715A (ko) 2012-11-27
DE602004011055D1 (de) 2008-02-14
BRPI0412924A (pt) 2006-09-26
HK1087907A1 (en) 2006-10-27
IL173345A (en) 2010-06-16
PT1638492E (pt) 2008-03-17
ATE382354T1 (de) 2008-01-15
ZA200510071B (en) 2006-11-29
NO326636B1 (no) 2009-01-26
JP2007500133A (ja) 2007-01-11
AU2004261181A1 (en) 2005-02-10
UA81689C2 (ru) 2008-01-25
MA28005A1 (fr) 2006-07-03
CA2529983A1 (en) 2005-02-10
IS8186A (is) 2005-12-19
KR20080011248A (ko) 2008-01-31
US20080026042A1 (en) 2008-01-31
PL1638492T3 (pl) 2008-06-30
EP1638492A2 (en) 2006-03-29
DE602004011055T2 (de) 2008-12-18

Similar Documents

Publication Publication Date Title
CY1109229T1 (el) Χρηση σπογγοσινης (2-μεθοξυαδενοσινης) για τη θεραπεια πονου, συγκεκριμενα υπερευαισθησιας στο πονο
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
MY145590A (en) Phenylacetamides and their use as glucokinase modulators
EA200600820A1 (ru) Способы лечения, модификации и устранения боли с использованием 1-оксо-2-(2,6-диоксопиперидин-3-ил)-4-метилизоиндолина
MY138059A (en) Use of ikb-kinase inhibitors in pain therapy
ATE359077T1 (de) Orale gabe von 6-hydroxy-oxymorphon als analgetikum
DE60223254D1 (de) Verzögert freisetzende formulierungen von oxymorphon
TR200002786T2 (tr) Meloksikam için yeni galenik bir formülasyon.
DK1365808T3 (da) Sammensætninger til antitumorbehandling indeholdende ecteinascidin 743
GB0130677D0 (en) Medicaments and novel compounds
CY1107352T1 (el) Προεγχειρητικη θεραπευτικη αγωγη μετεγχειρητικου πονου
ATE543491T1 (de) Kombinationspräparat enthaltend ibuprofen und paracetamol
SE9902267D0 (sv) New compounds
TW200503683A (en) Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain
EA200200853A1 (ru) Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
SE0004827D0 (sv) Therapeutic compounds
EA200401454A1 (ru) Новая комбинация из обратимо действующих ингибиторов протонного насоса и используемых в терапии дыхательных путей лекарственных веществ, предназначенных для лечения респираторных заболеваний
SE0203817D0 (sv) New composition
ATE371446T1 (de) Zusammensetzungen zur verhinderung der adhäsion
NO20043774L (no) The use of devazenide as analgesic agent
ATE493976T1 (de) Bakuchiol enthaltende pharmazeutische zusammensetzung zur behandlung von weiblicher osteoporose
ATE411014T1 (de) Bakuchiol enthaltende pharmazeutische zusammensetzung zur behandlung von weiblichem brustkrebs